ASPISMEDICAL achieves a 451% surge in global readership

Written By General Directorate for Communications

ASPISMEDICAL, the official medical journal of Counter-Terrorism Medicine Europe (CTM-E), has experienced an unprecedented surge in global reach, reflecting the rapidly growing demand for specialised knowledge in counter-terrorism medicine, disaster resilience, and tactical medical response.

Thanks to the dedicated efforts of our Editor-in-Chief, John Galatas, the community of authors, reviewers, and frontline professionals, ASPISMEDICAL has achieved an astonishing 451% increase in readership compared to last year.

This exponential growth highlights a vital shift in the international medical community—the recognition of Counter-Terrorism Medicine as an essential, distinct discipline. Our insights, research, and operational protocols are now reaching those who need them most, spanning continents and jurisdictions.

  • 451% Growth: An overwhelming increase in year-over-year engagement.

  • 91 Countries: ASPISMEDICAL is now actively read and utilised by healthcare professionals, tactical medics, and security researchers across 91 nations with a record number of readers from the United States, the United Kingdom, Italy and France.

This massive expansion underscores the universal necessity of standardising medical responses to asymmetric threats, CBRNe incidents, and mass casualty events.

From deep-dive epidemiological analyses of historical threats to cutting-edge innovations in battlefield medicine, ASPISMEDICAL remains committed to delivering high-impact, actionable science.

The complete breakdown of these readership metrics, regional growth statistics, and our upcoming editorial roadmap will be officially published in the forthcoming CTM-E Annual Report.

General Directorate for Communications

Next

Alex Grant delivers session on high-threat operational medicine to students at the Buckinghamshire New University Paramedicine Society